Abemaciclib
From Proteopedia
| ||||||||||||
Abemaciclib, sold under the brand name Verzenio among others, is a medication for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6.[3]
| ||||||||||||
This page was last modified 06:51, 23 October 2023.